3 results match your criteria: "Breach Candy Medical Research Centre[Affiliation]"
Indian J Cancer
December 1998
Breach Candy Medical Research Centre, Mumbai, India.
The objective of this study on bladder lesions was to assess the relationship of (a) the proliferative activity measured by AgNOR counts, and (b) the loss of cell adhesion leading to acquisition of invasive properties as assessed by E-Cadherin expression. Paraffin embedded tissue biopsies from normal urothelium and malignant urothelial lesions were randomly selected from our surgical pathology files. AgNORs were analysed by the silver staining method and E_cadherin expression by immunohistochemistry.
View Article and Find Full Text PDFTumori
January 1999
Department of Immunology, Breach Candy Medical Research Centre, Bombay, India.
Parsis, the sole surviving group of followers of Zoroaster who are settled in Bombay, have a fourfold higher incidence of breast cancer than the general population of Greater Bombay. CD44 expression was studied by immunohistochemistry in breast cancers of 50 non-Parsi and 35 Parsi women, 10 normal breast tissues, 10 proliferative lesions and 49 tissues adjoining a tumor mass. Alpha2 and beta1 integrins could be studied in only 42 malignant cases and five normal tissues.
View Article and Find Full Text PDFIndian J Cancer
December 1995
Breach Candy Medical Research Centre, Bombay, India.
One hundred cervical tissues including 72 malignancies (68 squamous cell carcinomas, 3 adenocarcinomas, 1 neuro-endocrine carcinoma), 24 cases of CIN of various grades and 4 normals were examined for the presence of Human Papilloma virus (HPV) types by non isotopic in-situ hybridisation. Biotinylated probes to HPV types 16 and 18 were used in all the cases and 31 and 33 in 15 squamous Carcinomas. HPV DNA sequences were detected in 55/72 (76.
View Article and Find Full Text PDF